3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
2
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Melanoma
1
Locally Advanced Rectal Adenocarcinoma
1
Locally Advanced Cervical Carcinoma
1
Liver Neoplasms
1
Liver Diseases
1
Head and Neck Neoplasms
1
Gastric Cancer With Liver Metastases
1
Esophageal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
18
Cisplatin
18
Cetuximab
13
Carboplatin
10
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Docetaxel
8
Paclitaxel
7
Radiotherapy, Intensity-Modulated
6
Platinum
6
Nivolumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
dostarlimab
4
Radiotherapy
4
Immunoglobulin G
4
Fluorouracil
4
Disulfides
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
atezolizumab
3
Radiation
3
Bevacizumab
3
cemiplimab
2
amivantamab
2
abemaciclib
2
Taxes
2
Fulvestrant
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Immunotherapy
×
30 days
×
Clear all
No trials found.